SNHG17 and lymphoma: SNHG17 knockdown inhibited EZH2 expression, while miR-34a-5p overexpression weakened this trend, suggesting that the SNHG17/miR-34a-5p axis may affect the biological function of lymphoid cancer cells and tumor development by regulating the activity of the EZH2 signaling pathway.